unknown
Stage
2025
Founded
1
Investors
About
Gesynta Pharma develops pharmaceutical treatments for inflammation, focusing on endometriosis and chronic inflammatory pain through the inhibition of the mPGES-1 enzyme.
Explore Gesynta's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.